EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

CHEMO-INDUCED ORAL COMPLICATIONS IN PATIENTS TREATED FOR CANCER AT THE YAOUNDE GENERAL HOSPITAL

Eyimi Abessolo François G.*, Ndoe Guiaro Marcellin, Atenguena Etienne, Ndom Paul and Bengondo Charles

ABSTRACT

Nowadays, surgery, radiotherapy, and chemotherapy are the most used cancer therapies. But the chemotherapy, because of its non-specificity towards neoplastic cells causes many complications among which the oral complications. About 40% of chemotherapy patients develop an oral complication and, this prevalence can go up to 76% in malignant hemopathies. In this study, our objectives were to determine the prevalence, frequency and average extension time for the occurrence of these complications at the Yaounde general hospital. In the other hand, the association of these complications with a few risk factors was evaluated. To achieve these objectives, we conducted a descriptive study over 6 months with prospective data collection in the oncology department of the General Hospital of Yaounde. Our sample was determined consecutively and randomly. The selected patients (1 patient = 1 file), after receiving their chemotherapy cure, were consulted on the 10th day to identify the sprung complications. When a statistical test was required, a value of p˂0.05 was considered to be statistically significant. 95 participants (36 men and 59 women) were included in our study. The prevalence of oral complications was 40%. and, four types of toxicity were observed in this population namely: the mucositis (44.74%), the xerostomia (26.32%), the dysgeusia (23.68%) and the oral candidiasis (5.26% ). These complications occurred after an average extension time of 08 days and seemed to be frequent in the female sex and in the age group of 30 to 40 years. The risk factors associated with these complications were: the young age (p = 0.025), the unpleasant oral health (p = 0.049; OR = 3.27; CI = [1.09-9.80] and HIV infection (p = 0.01; OR = 4.78; CI = [1.39-16.41]. Thus, chemo-induced oral complications are a reality in Cameroon with a prevalence of 40% reported at the end of this study.

Keywords: .


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 May 2020 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR MAY ISSUE PUBLISHED

    MAY 2020 Issue has been successfully launched on 1 May 2020.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing